ArticleInternational journal of clinical oncology2021

Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients.

Tsuyoshi Takeda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.